How Genetically Engineered Mouse Tumor Models Provide Insights Into Human CancersPOLITI, Katerina; PAO, William.Journal of clinical oncology. 2011, Vol 29, Num 16, pp 2273-2281, issn 0732-183X, 9 p.Article

Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer : Current knowledge and future directionsPAO, William; MILLER, Vincent A.Journal of clinical oncology. 2005, Vol 23, Num 11, pp 2556-2568, issn 0732-183X, 13 p.Article

Highly Active Antitumor Therapy (HAATT) for Epidermal Growth Factor Receptor-Mutant Lung CancerCHMIELECKI, Juliann; PAO, William.Clinical cancer research (Print). 2010, Vol 16, Num 22, pp 5371-5373, issn 1078-0432, 3 p.Article

Three-dimensional finite element simulation of three-phase flow in a deforming fissured reservoirPAO, William K. S; LEWIS, Roland W.Computer methods in applied mechanics and engineering. 2002, Vol 191, Num 23-24, pp 2631-2659, issn 0045-7825Article

Epidural abscess and vertebral osteomyelitis caused by Listeria monocytogenes : Case report and literature reviewKHAN, Kamran M; PAO, William; KENDLER, Jason et al.Scandinavian journal of infectious diseases. 2001, Vol 33, Num 9, pp 714-716, issn 0036-5548Article

Association of KRAS and EGFR Mutations With Survival in Patients With Advanced Lung AdenocarcinomasJOHNSON, Melissa L; SIMA, Camelia S; CHAFT, Jamie et al.Cancer. 2013, Vol 119, Num 2, pp 356-362, issn 0008-543X, 7 p.Article

ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK InhibitorsHEUCKMANN, Johannes M; HÖLZEL, Michael; RAUH, Daniel et al.Clinical cancer research (Print). 2011, Vol 17, Num 23, pp 7394-7401, issn 1078-0432, 8 p.Article

Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non―Small-Cell Lung CancerJACKMAN, David; PAO, William; RIELY, Gregory J et al.Journal of clinical oncology. 2010, Vol 28, Num 2, pp 357-360, issn 0732-183X, 4 p.Article

A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancerMILTON, Daniel T; AZZOLI, Christopher G; MILLER, Vincent A et al.Cancer. 2006, Vol 107, Num 5, pp 1034-1041, issn 0008-543X, 8 p.Article

Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomasPHAM, Duykhanh; KRIS, Mark G; WILSON, Richard K et al.Journal of clinical oncology. 2006, Vol 24, Num 11, pp 1700-1704, issn 0732-183X, 5 p.Article

EGFR Mutant Lung CancerYIXUAN GONG; PAO, William.Current Topics in Microbiology and Immunology. 2012, Vol 355, pp 59-81, issn 0070-217X, 23 p.Article

Beyond Histology: Translating Tumor Genotypes into Clinically Effective Targeted TherapiesMEADOR, Catherine B; MICHEEL, Christine M; VNENCAK-JONES, Cindy L et al.Clinical cancer research (Print). 2014, Vol 20, Num 9, pp 2264-2275, issn 1078-0432, 12 p.Article

Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted DrugsKRIS, Mark G; JOHNSON, Bruce E; YU SHYR et al.JAMA, the journal of the American Medical Association. 2014, Vol 311, Num 19, pp 1998-2006, issn 0098-7484, 9 p.Article

ROS1 Rearrangements Define a Unique Molecular Class of Lung CancersBERGETHON, Kristin; SHAW, Alice T; MARK, Eugene J et al.Journal of clinical oncology. 2012, Vol 30, Num 8, pp 863-870, issn 0732-183X, 8 p.Article

Rebiopsy of Lung Cancer Patients with Acquired Resistance to EGFR Inhibitors and Enhanced Detection of the T790M Mutation Using a Locked Nucleic Acid-Based AssayARCILA, Maria E; OXNARD, Geoffrey R; NAFA, Khedoudja et al.Clinical cancer research (Print). 2011, Vol 17, Num 5, pp 1169-1180, issn 1078-0432, 12 p.Article

Integration of Molecular Profiling into the Lung Cancer ClinicPAO, William; KRIS, Mark G; LYNCH, Thomas J et al.Clinical cancer research (Print). 2009, Vol 15, Num 17, pp 5317-5322, issn 1078-0432, 6 p.Article

Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon19 and exon 21 mutations treated with gefitinib or erlotinibRIELY, Gregory J; PAO, William; PHAM, Duykhanh et al.Clinical cancer research. 2006, Vol 12, Num 3, pp 839-844, issn 1078-0432, 6 p., 1Article

Update on epidermal growth factor receptor mutations in non-small cell lung cancerRIELY, Gregory J; POLITI, Katerina A; MILLER, Vincent A et al.Clinical cancer research. 2006, Vol 12, Num 24, pp 7232-7241, issn 1078-0432, 10 p.Article

Finite element analysis and approximate estimation of the cross coupling effect in fractured reservoirsLEWIS, Roland W; PAO, William K. S; YANG, Xin-She et al.Geophysical research letters. 2003, Vol 30, Num 14, pp HLS1.1-HLS1.4, issn 0094-8276Article

Differential Protein Stability and ALK Inhibitor Sensitivity of EML4-ALK Fusion VariantsHEUCKMANN, Johannes M; BALKE-WANT, Hyatt; KÜPPERS, Ralf et al.Clinical cancer research (Print). 2012, Vol 18, Num 17, pp 4682-4690, issn 1078-0432, 9 p.Article

Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer: Distinct Natural History of Patients with Tumors Harboring the T790M MutationOXNARD, Geoffrey R; ARCILA, Maria E; SIMA, Camelia S et al.Clinical cancer research (Print). 2011, Vol 17, Num 6, pp 1616-1622, issn 1078-0432, 7 p.Article

Core Needle Lung Biopsy Specimens: Adequacy for EGFR and KRAS Mutational AnalysisSOLOMON, Stephen B; ZAKOWSKI, Maureen F; PAO, William et al.American journal of roentgenology (1976). 2010, Vol 194, Num 1, pp 266-269, issn 0361-803X, 4 p.Article

Use of Epidermal Growth Factor Receptor/ Kirsten Rat Sarcoma 2 Viral Oncogene Homolog Mutation Testing to Define Clonal Relationships Among Multiple Lung Adenocarcinomas: Comparison With Clinical GuidelinesGIRARD, Nicolas; DESHPANDE, Charuhas; AZZOLI, Christopher G et al.Chest (American College of Chest Physicians). 2010, Vol 137, Num 1, pp 46-52, issn 0012-3692, 7 p.Article

Comprehensive Histologic Assessment Helps to Differentiate Multiple Lung Primary Nonsmall Cell Carcinomas From MetastasesGIRARD, Nicolas; DESHPANDE, Charuhas; LAU, Christopher et al.The American journal of surgical pathology. 2009, Vol 33, Num 12, pp 1752-1764, issn 0147-5185, 13 p.Article

Molecular Characteristics of Bronchioloalveolar Carcinoma and Adenocarcinoma, Bronchioloalveolar Carcinoma Subtype, Predict Response to ErlotinibMILLER, Vincent A; RIELY, Gregory J; HERBST, Roy S et al.Journal of clinical oncology. 2008, Vol 26, Num 9, pp 1472-1478, issn 0732-183X, 7 p.Article